Brief: GNS Holdings' Long Position In Genscript Biotech Increased To 8.42% On May 14 - HKEX Filing
May 21 (Reuters) - Hong Kong stock exchange filing:
* GNS HOLDINGS LIMITED'S LONG POSITION IN GENSCRIPT BIOTECH
CORP
1548.HK INCREASED TO 8.42% ON MAY 14 FROM 0% - HKEX FILING
Source text in English: https://bit.ly/3f7AYNf
Further company coverage: 1548.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale